IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company pioneering next-generation therapeutics for cardiovascular disease, today announced a strategic collaboration to accelerate the development of cardiac gene therapies and human-based drug discovery platforms.